Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy

Detalles Bibliográficos
Autores principales: Vanni, Kathleen MM, Patel, Naomi J, DiIorio, Michael, Kowalski, Emily, Qian, Grace, Cook, Claire E, Ritter, Susan Y, Wallace, Zachary S, Sparks, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811273/
https://www.ncbi.nlm.nih.gov/pubmed/35110366
http://dx.doi.org/10.1136/rmdopen-2021-002082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811273/
https://www.ncbi.nlm.nih.gov/pubmed/35110366
http://dx.doi.org/10.1136/rmdopen-2021-002082

Ejemplares similares